Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iliofascial block effect on spinal ropivacaine dose in elderly hip fracture surgery
ChiCTR2500103467Phase 4Completed
- Sponsor
- Hainan General Hospital
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine in hip fracture (2 arms), sponsored by Hainan General Hospital. Primary endpoint: Half effective dose of ropivacaine required for lumbar anesthesia and 95% confidence interval. Started May 2025; status: completed.
02
Drugs
ropivacaine
03
Conditions
hip fracture
Beyond the preview
Go deeper on ChiCTR2500103467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103467.